India & Eli Lilly and Company
14 shared events · Importance 4 · Last updated Aug 04, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
India: India's healthcare sector benefits from the availability of a new targeted cancer therapy, Tanstrive, which addresses a specific genetic alteration in various solid tumors. This improves treatment options for Indian patients.
Eli Lilly and Company: Eli Lilly and Company has launched its cancer drug Tanstrive in India, expanding its market presence and offering a new treatment option for patients with RET-altered cancers. This launch is expected to positively impact the company's revenue and reputation in the Indian market.
Jun 25, 2026 · 7 articles
Business
India: India is a key battleground for weight-loss drugs due to its large obesity population and is experiencing significant competition between Novo Nordisk and Eli Lilly and Company.
Eli Lilly and Company: Eli Lilly and Company's drug Tirzepatide has been a strong competitor to Semaglutide in India, prompting Novo Nordisk to cut prices. Eli Lilly and Company has gained significant market share.
Nov 11, 2025 · 6 articles
International
India: As an oil-importing country, India>>> benefited from stable crude oil prices, which supported the India — Indian rupee>>>.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
Regulatory
India: India is the country where the approval was granted; the decision addresses a significant public health burden of fatty liver disease.
Eli Lilly and Company: Eli Lilly competes with Novo Nordisk in India's obesity-drug market with Mounjaro; the approval may intensify competition.
Jul 17, 2026 · 13 articles
Business
India: India gains access to its first disease-modifying Alzheimer's therapy, addressing a significant dementia burden, though adoption faces challenges.
Eli Lilly and Company: Eli Lilly faces increased competition in India's Alzheimer's market as Eisai launches Leqembi, potentially impacting its Lormalzi uptake.
Aug 03, 2026 · 6 articles
Business
India: India's regulatory action led Lilly to pause its campaign, highlighting cross-market regulatory risks.
Eli Lilly and Company: Lilly leads GLP-1 sales in China and runs prominent awareness campaigns, though it paused its India campaign. Its Mounjaro is gaining patient demand.
Aug 24, 2026 · 6 articles
Business
India: India becomes the seventh country to launch Awiqli, addressing its high diabetes burden and potentially improving public health outcomes.
Eli Lilly and Company: Eli Lilly competes with Novo Nordisk in the obesity treatment market, but this launch is focused on diabetes.
Jul 09, 2026 · 21 articles
Business
India: Cipla's India business posted record quarterly sales of Rs 3,452 crore, growing 12%, with strong performance in chronic therapies.
Eli Lilly and Company: Cipla markets obesity drug Yurpeak under a licensing agreement with Eli Lilly; Yurpeak became the second-largest GLP-1 brand in India.
Jul 23, 2026 · 6 articles
Business
India: Sensex nearly unchanged.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
India: Country affected by shipping disruptions, with a ship sunk in the Red Sea, but not directly involved in Hormuz.
Eli Lilly and Company: Eli Lilly and Company raised its forecast, boosting healthcare stocks. It is not connected to the event.
Mar 09, 2018 · 316 articles
Business
Eli Lilly and Company: Eli Lilly and Company is a competitor in the Indian weight-loss drug market with its product Mounjaro, which has seen greater uptake than Novo Nordisk's Wegovy.
Nov 10, 2025 · 6 articles
40
Eli Lilly and Company paused campaign IndiaGLP-1 drugmakers obesity...
ERGEN INTELLIGENCE
Explore this relationship live
Track how India and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard